R. Arriga

发表

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism

D. Lauro, M. Scioli, A. Orlandi, 2019, Oxidative medicine and cellular longevity.

Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia

M. Federici, D. Lauro, D. Della-Morte, 2015, Acta Diabetologica.

NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma

D. Lauro, A. Venditti, F. Buccisano, 2015, Front. Med..

NK cells and T cells cooperate during the clinical course of colorectal cancer

L. Terracciano, S. Ferrone, D. Lauro, 2014, Oncoimmunology.

Insulin and Exendin-4 Reduced Mutated Huntingtin Accumulation in Neuronal Cells

D. Lauro, D. Della-Morte, N. Di Daniele, 2020, Frontiers in Pharmacology.

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.

F. Guadagni, P. Abete, D. Lauro, 2016, Pharmacological research.

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

S. Ferrone, D. Lauro, A. Venditti, 2017, Front. Immunol..

T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.

D. Lauro, C. Palumbo, Maria Michela D’Aloia, 2016, Cytotherapy.

Activation of Peripheral Blood Mononuclear Cells and Leptin Secretion: New Potential Role of Interleukin-2 and High Mobility Group Box (HMGB)1

D. Lauro, R. Lauro, D. Della-Morte, 2021, International journal of molecular sciences.

CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab

S. Ferrone, D. Lauro, M. Roselli, 2020, International journal of cancer.

CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab

S. Ferrone, D. Lauro, M. Roselli, 2019, bioRxiv.

EGFR GLIOBLASTOMA STEM CELLS TARGETING BY CD16158V CHIMERIC RECEPTOR T CELLS AND CETUXIMAB

D. Lauro, M. Roselli, A. Venditti, 2021, Annals of Research in Oncology.

HLA‐DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma

D. Lauro, A. Orlandi, O. Buonomo, 2015, International journal of cancer.

SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α

D. Noto, M. Federici, D. Lauro, 2015, Cell Death and Disease.

Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.

A. Urbani, M. Federici, D. Lauro, 2015, American journal of physiology. Endocrinology and metabolism.

In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab

S. Ferrone, D. Lauro, A. Venditti, 2019, International journal of cancer.

Elimination of Egfr-Overexpressing Cancer Cells by CD32 Chimeric Receptor T Cells in Combination with Cetuximab or Panitumumab

S. Ferrone, D. Lauro, A. Venditti, 2019, bioRxiv.

Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment

K. Rezvani, S. Baldari, Ken Chen, 2022, Life Science Alliance.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

L. Terracciano, C. Ferrone, S. Ferrone, 2014, Neoplasia.

Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes.

M. Roselli, R. Arriga, G. Sconocchia, 2019, Biochemical pharmacology.

HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker 1 , 2

L. Terracciano, C. Ferrone, S. Ferrone, 2014 .

Insights into Pathophysiology, Limitations, and Perspectives Transgenic and Knockout Mice in Diabetes Research: Novel

S. Ylä-Herttuala, J. Brüning, M. Federici, 2015 .

Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment

K. Rezvani, S. Baldari, Ken Chen, 2021, bioRxiv.

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models

G. Ciliberto, C. Castilletti, M. Capobianchi, 2021, Molecular Therapy.

COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19

G. Ciliberto, G. Ippolito, C. Castilletti, 2021, bioRxiv.

Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase.

M. Federici, D. Lauro, D. Della-Morte, 2016, Rejuvenation research.

Peroxiredoxin 6, a Novel Player in the Pathogenesis of Diabetes

M. Federici, D. Lauro, M. Scioli, 2014, Diabetes.

Prdx6 Plays a Main Role in the Crosstalk between Aging and Metabolic Sarcopenia

P. Abete, D. Lauro, M. Scioli, 2020, Antioxidants.

Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients

A. Gaspari, A. Orlandi, R. Bei, 2015, Journal of Translational Medicine.

Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients

A. Gaspari, A. Orlandi, R. Bei, 2015, Journal of Translational Medicine.

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage

S. Ferrone, D. Lauro, A. Venditti, 2015, Oncotarget.

Melanoma cells inhibit NK cell functions.

L. Terracciano, S. Ferrone, R. Arriga, 2012, Cancer research.

Liver Protein Profiles in Insulin Receptor Knockout Mice Reveal Novel Molecules

D. Della-Morte, R. Arriga, F. Pacifici, 2015 .